Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for cancer and autoimmune diseases. Using single-cell precision, Orca Bio’s innovative products aim to replace diseased blood and immune systems, offering safer, more effective alternatives to standard treatments. Their mission is to transform patient care through advanced allogeneic cell therapies.
